Goldcoasthealthplan Coverage Criteria
Latest Goldcoasthealthplan coverage criteria updates25
- Coverage CriteriaClinical/Medical PolicyEff. 2026-09-03CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMSThis policy provides guidance on coverage criteria, provider requirements, documentation, utilization controls, billing, and patient education for continuous glucose monitors, blood glucose monitoring supplies, and insulin delivery devices for eligible Total Care Advantage Medicare beneficiaries.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-06-04Clinical Decision-MakingThis policy governs how Gold Coast Health Plan and contracted providers evaluate medical necessity and coverage criteria for clinical services, including investigational or experimental services, using evidence-based guidance while considering members’ social and structural drivers of health.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-14RYBREVANT and RYBREVANT FASPRO Coverage for EGFR-Mutated Non-Small Cell Lung CancerPrior authorization and Part B coverage criteria for physician-administered intravenous RYBREVANT and subcutaneous RYBREVANT FASPRO in adults with recurrent, advanced, or metastatic NSCLC and qualifying EGFR mutations.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-02-12Voraxaze (glucarpidase) Injection CoveragePart B coverage and prior authorization for provider-administered intravenous Voraxaze in adult and pediatric patients with toxic methotrexate concentrations and delayed clearance due to impaired renal function.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-11-13Emrelis (telisotuzumab vedotin-tllv) Coverage CriteriaThis policy governs prior authorization and Part B medical coverage for physician-administered intravenous Emrelis in adults with specified locally advanced or metastatic non-squamous non-small cell lung cancer. It establishes the covered indication, clinical approval criteria, dosing, administration setting, monitoring, and authorization duration.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-11-13LYNOZYFIC (linvoseltamab-gcpt) Coverage Criteria for Relapsed or Refractory Multiple MyelomaThis policy governs prior authorization and Part B coverage for physician-administered intravenous LYNOZYFIC in adults with relapsed or refractory multiple myeloma. It establishes FDA-indication requirements, prior-treatment history, dosing, monitoring, site-of-care, and documentation requirements.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-11-13ZIIHERA (zanidatamab-hrii) IV Therapy Coverage CriteriaThis policy governs Part B coverage and prior authorization for intravenous ZIIHERA in adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer. It specifies the covered indication, dosing regimen, treatment duration, infusion timing, and billing identifiers.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Adakveo (crizanlizumab) Coverage CriteriaMedicare Part B prior authorization and coverage for Adakveo in patients aged 16 years and older with sickle cell disease, including indication, documentation, hydroxyurea step therapy, coding, dose, and coverage duration requirements.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Alyglo (immune globulin intravenous, human-stwk) Coverage CriteriaMedicare Part B prior authorization and coverage criteria for Alyglo in adults with primary humoral immunodeficiency, including documentation, dosing, coverage duration, and HCPCS billing requirements.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Benlysta IV (belimumab) Coverage CriteriaMedicare Advantage Part B coverage and prior authorization criteria for intravenous Benlysta in patients aged 5 years and older with active systemic lupus erythematosus or active lupus nephritis receiving standard therapy.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Bivigam (immune globulin) Coverage CriteriaThis policy governs prior authorization and Medicare Part B coverage for Bivigam (immune globulin) administered intravenously. It applies to providers requesting coverage for eligible autoimmune, infectious, idiopathic, and other medically appropriate uses supported by the applicable Medicare LCD and medical records.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Boniva IV (ibandronate sodium) Coverage CriteriaThis policy governs prior authorization and Part B coverage of Boniva IV for osteoporosis in postmenopausal women. Supporting medical records and compliance with LCD L34648 are required.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Cinqair (reslizumab) Coverage CriteriaThis policy governs prior authorization and Part B coverage of Cinqair (reslizumab) for Medicare Advantage members with severe eosinophilic asthma requiring add-on therapy. It specifies covered use, clinical documentation, eosinophil thresholds, prescriber qualifications, exclusions, billing, and authorization duration.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Cinryze (C1 esterase inhibitor [human]) Coverage CriteriaMedicare Advantage Part B prior authorization and coverage for Cinryze used for routine prophylaxis against hereditary angioedema attacks in adults, adolescents, and children age 6 years and older.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Evenity (romosozumab-aqqg) Coverage CriteriaThis policy governs prior authorization and Part B coverage of Evenity for osteoporosis in postmenopausal women at high risk for fracture or patients who have failed or cannot tolerate other osteoporosis therapies. It applies to providers requesting coverage under the Total Care Advantage Medicare Part B benefit.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Fasenra (benralizumab) Coverage CriteriaMedicare Part B coverage and prior authorization for Fasenra (benralizumab) used for severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA), including clinical documentation, prescribing qualifications, dosing, and billing requirements.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Leqvio (inclisiran) Coverage CriteriaMedicare Advantage Part B prior authorization and coverage criteria for Leqvio in adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease who require additional LDL-C lowering.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Nucala (mepolizumab) Coverage CriteriaThis policy governs Part B prior authorization and coverage criteria for Nucala (mepolizumab) for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. It applies to providers requesting initial coverage or reauthorization for eligible members.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Ohtuvayre (ensifentrine) Coverage CriteriaPrior authorization and Medicare Part B or Part D benefit review for Ohtuvayre maintenance treatment of COPD in eligible adults, including initial coverage and reauthorization.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Onpattro (patisiran) Coverage CriteriaThis policy governs prior authorization and Medicare Part B coverage of Onpattro for adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis. It specifies clinical eligibility, exclusions, documentation, dosing, and reauthorization requirements.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Oxlumo (lumasiran) Coverage CriteriaThis policy governs prior authorization and Part B coverage of Oxlumo (lumasiran) for pediatric and adult patients with primary hyperoxaluria type 1, including requirements for diagnosis confirmation, specialist involvement, supporting documentation, and documented clinical benefit for reauthorization.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Ozurdex (dexamethasone, intravitreal implant) Coverage CriteriaThis policy governs prior authorization and Part B coverage for Ozurdex for specified retinal and ocular inflammatory conditions under Gold Coast Health Plan Medicare Advantage.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Prolia (denosumab) Coverage CriteriaThis policy governs prior authorization and Part B coverage for Prolia (denosumab) in eligible Medicare Advantage members. It defines covered osteoporosis uses, required documentation, applicable therapy history, billing information, and the maximum coverage duration.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Rebyota Coverage CriteriaThis policy governs prior authorization and Medicare Part B coverage for Rebyota (fecal microbiota live-jslm) for members aged 18 years or older following antibiotic treatment for recurrent Clostridioides difficile infection.All goldcoasthealthplan updates
- Coverage CriteriaClinical/Medical PolicyEff. 2025-08-21Ryplazim (plasminogen, human-tvmh) Coverage CriteriaMedicare Part B coverage and prior authorization criteria for Ryplazim in patients with plasminogen deficiency type 1 (hypoplasminogenemia).All goldcoasthealthplan updates
Tool Description
Search Goldcoasthealthplan coverage criteria and medical necessity requirements across 21,000+ policies from 170+ payers.
Search a drug (“Wegovy”), a procedure (“knee replacement”), or a policy name, then filter by payer, specialty, policy type, or effective year. Or start from the largest publishers: UnitedHealthcare coverage criteria and Cigna coverage criteria.
Each result links the full policy page, which lists the clinical requirements, covered codes, and effective dates from the source document.
Pair a criteria search with the prior authorization lookup for approval requirements, the timely filing lookup for claim deadlines, the live policy updates feed for the newest payer publications, and payer profiles for contacts and coverage context.
FAQ
Coverage Criteria by Payer
Go deeper
Explore OpenPayer Data
Coverage policies are updated every day. Follow payer coverage policy updates in the live policy feed, or browse all CPT, HCPCS and DRG billing codes.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Prior Authorization LookupSearch payer prior authorization policies by drug, procedure, or policy name.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.